Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design

Author:

Hobson Adrian D.1ORCID,Judge Russell A.2,Aguirre Ana L.2,Brown Brian S.2,Cui Yifang3,Ding Ping1,Dominguez Eric1,DiGiammarino Enrico2,Egan David A.2,Freiberg Gail M.2,Gopalakrishnan Sujatha M.2,Harris Christopher M.1,Honore Marie P.2,Kage Karen L.2,Kapecki Nicolas J.2,Ling Christopher2,Ma Junli2,Mack Helmut3,Mamo Mulugeta2,Maurus Stefan3,McRae Bradford1,Moore Nigel S.1,Mueller Bernhard K.3,Mueller Reinhold3,Namovic Marian T.2,Patel Kaushal2,Pratt Steve D.2,Putman C. Brent2,Queeney Kara L.1,Sarris Kathy K.2,Schaffter Lisa M.1,Stoll Vincent2,Vasudevan Anil2ORCID,Wang Lei1,Wang Lu1,Wirthl William1,Yach Kimberly1

Affiliation:

1. AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States

2. AbbVie, Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States

3. AbbVie Deutschland GmbH & Co. KG, Knollstrasse 50, 67061, Ludwigshafen, Germany

Funder

AbbVie

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3